Beactica awarded funding to develop therapeutics against brain tumours
Beactica, the Swedish drug discovery company, announced it has been awarded 2 MSEK (around $240 000) by the Swedish Governmental Agency for Innovation Systems (Vinnova) to advance its LSD1 programme